This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

TD Cowen Sticks to Their Hold Rating for Renaissancere Holdings (RNR)

Tipranks - Tipranks - Tue May 19, 6:52AM CDT

In a report released on May 15, Tyler Van Buren from TD Cowen maintained a Hold rating on Renaissancere Holdings. The company’s shares closed last Friday at $294.23.

Claim 55% Off TipRanks

According to TipRanks, Van Buren is a 5-star analyst with an average return of 26.3% and a 54.60% success rate. Van Buren covers the Healthcare sector, focusing on stocks such as Allogene Therapeutics, Soleno Therapeutics, and Summit Therapeutics.

Currently, the analyst consensus on Renaissancere Holdings is a Hold with an average price target of $322.89, implying a 9.74% upside from current levels. In a report released on May 5, KBW also maintained a Hold rating on the stock with a $327.00 price target.

See the top stocks recommended by analysts >>

Based on Renaissancere Holdings’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $2.17 billion and a net profit of $293.38 million. In comparison, last year the company earned a revenue of $3.45 billion and had a net profit of $169.99 million

Read More on RNR:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).